Remuneration

Fiscal year 2021/22

1. Total annual spending on remuneration paid to full-time permanent employees was $16,506,100 for the year ended December 31, 2021.

2. Total number of full-time permanent employees as of March 31, 2022, is 122.

3. Total compensation for the year ended December 31, 2021 (as reported on 2021 T4), for the following employees:

Title Remuneration (2021 T4 slips) Taxable benefits (included in remuneration figure)
Chief Executive Officer (1)*
Chief Executive Officer (2)*
$649,579.81
$72,793.28
$32,971.53
$0
VP, Cancer Control (1)
VP, Cancer Control (2)
$548,600.69
$27,610.56
$7,648.47
$0
VP, Finance & Corporate Services $297,537.03 $9,656.89
VP, Strategic Partnerships $283,870.12 $4,990.50
VP, Cancer Systems, Performance, & Innovation $284,960.58 $6,080.96

*CEO taxable benefits included RRSP contributions, accrued vacation pay and insured benefit premiums.

4. Partnership staff salary ranges (in effect as of March 31, 2022):

Level Position Annual remuneration range Number of full-time permanent
employees
9 Senior Director $139,542 – $192,075 9
8 Director, Leads $116,285 – $160,063 6
7 Managers, Program Managers, Controller, Specialists, Leads, Delivery Managers, Enterprise Architect $96,904 – $133,386 29
6 Analysts, Program Managers, Service Manager, Specialists, Senior Accountant, Web Developer, Delivery Managers, Leads $77,523 – $104,885 44
5 Analysts, Officers, Delivery Managers $68,003 – $92,003 12
4b Senior Executive Assistants $59,326 – $80,705 3
4 Coordinators $52,326 – $70,794 8
3 Administrative Assistants $45,900 – $62,100 6
  TOTAL 122*

*Includes 122 employees + 5 executives

5. Total remuneration paid to Partnership Board members for the year ended December 31, 2021 (as reported to Revenue Canada on 2021 T4 slips), was $150,200.

Partnership remuneration